This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Pf Argentum IP Holdings LLC, Pfizer Corporation. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Penka Slavcheva Slavova-Petrova: Innovator in Cancer Therapy
Introduction
Penka Slavcheva Slavova-Petrova is a notable inventor based in Toronto, Canada. She has made significant contributions to the field of cancer therapy, particularly through her innovative approaches to CD47 blockade therapy. With a total of 2 patents, her work focuses on enhancing the effectiveness of cancer treatments.
Latest Patents
One of her latest patents involves a method for CD47 blockade therapy using HDAC inhibitors. This therapy targets CD47-disease cells, such as cancer cells, by combining a CD47 blockade drug with a histone deacetylase (HDAC) inhibitor. The anti-cancer effects of these drugs are synergistic, enhancing each other's efficacy. Specific combinations include SIRPαFc as the CD47 blockade drug, along with either depsipeptide or romidepsin as the HDAC inhibitor. This combination is particularly useful for treating blood cancers, including lymphomas, leukemias, and myelomas.
Another significant patent focuses on enhancing CD47 blockade therapy through the use of proteasome inhibitors. In this method, CD47-disease cells are treated with a combination of a CD47 blockade drug and a proteasome inhibitor. Similar to her previous patent, the anti-cancer effects of these drugs work together to improve treatment outcomes. Specific combinations include SIRPαFc as the CD47 blockade drug, along with bortezomib, ixazomib, or carfilzomib as the proteasome inhibitor. This approach is also aimed at treating blood cancers effectively.
Career Highlights
Throughout her career, Penka has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Pf Argentum IP Holdings LLC. Her experience in these organizations has contributed to her expertise in developing innovative cancer therapies.
Collaborations
Penka has collaborated with talented individuals in her field, including Emma Linderoth and Natasja Nielsen Viller. These partnerships have likely enriched her research and development efforts.
Conclusion
Penka Slavcheva Slavova-Petrova is a pioneering inventor whose work in cancer therapy is making a significant impact. Her innovative approaches to CD47 blockade therapy demonstrate her commitment to improving treatment options for patients with blood cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile